Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2015 | Future directions for the treatment of diffuse large B-cell lymphoma

At the 20th Congress of the European Hematology Association (EHA), Christian Gisselbrecht, MD, of Paris Diderot University, Paris, France, highlights the unmet clinical needs and emerging therapeutic options for patients with diffuse large B-cell lymphoma (DLBCL). Research is moving towards targeted agents that utilize the improved understanding of disease biology in patient subgroups with the poorest prognoses.